BIOPHARMACEUTICALS BIOCHEMISTRY AND BIOTECHNOLOGY - PART 9 potx
BIOPHARMACEUTICALS BIOCHEMISTRY AND BIOTECHNOLOGY - PART 9 potx
... 324–3 29. Ohagan, D. et al. ( 199 7). Recent advances in vaccine adjuvants — the development of Mf 59 emulsion and polymeric microparticles. Mol. Med. Today 3(2), 69 75. Perkus, M. et al. ( 199 5). ... and use of vaccine adjuvants. Mol. Biotechnol. 21(2), 1 29 148. Esparza, J. et al. ( 199 5). HIV-preventive vaccines, progress to date. Drugs 50(5), 792 –804. Frontiers in Medicine: Vacci...
Ngày tải lên: 13/08/2014, 07:20
BIOPHARMACEUTICALS BIOCHEMISTRY AND BIOTECHNOLOGY - PART 1 potx
... therapeutic 8 BIOPHARMACEUTICALS Interleukin-1 (IL-1) 232 The biological activities of IL-1 233 IL-1 biotechnology 234 Interleukin-3: biochemistry and biotechnology 235 Interleukin-4 236 Interleukin-6 238 Interleukin-11 ... 290 TGF-a 290 TGF-b 292 Neurotrophic factors 293 The neurotrophins 294 Neurotrophin receptors 296 The neurotrophin low-affinity recep tor 297 Ciliary neurot...
Ngày tải lên: 13/08/2014, 07:20
BIOPHARMACEUTICALS BIOCHEMISTRY AND BIOTECHNOLOGY - PART 2 potx
... Post, L. ( 199 9). Novel Therapeutics from Modern Biotechnology. Springer-Verlag, Berlin. Pezzuto, J. ( 199 3). Biotechnology and Pharmacy. Chapman & Hall, London. Reese, R. (2000). Handbook of ... 338–342. Gournelis, D. et al. ( 199 7). Cyclopeptide alkaloids. Nat. Prod. Rep. 14(1), 75–82. Hancock, R. ( 199 7). Peptide antibiotics. Lancet 3 49( 90 49) , 418–422. Kalant, H. ( 199 7)....
Ngày tải lên: 13/08/2014, 07:20
BIOPHARMACEUTICALS BIOCHEMISTRY AND BIOTECHNOLOGY - PART 3 potx
... & Co Ltd from Walsh & Headon ( 199 4) Particulate matter Soil particles Dirt particles Particles derived from decaying organic matter, such as leaves Particles derived from leaching of internal ... membranes can remove 95 % of all dissolved solids and 99 % of microorganisms and endotoxins. Double RO systems are often employed, increasing the efficiency of the process still further...
Ngày tải lên: 13/08/2014, 07:20
BIOPHARMACEUTICALS BIOCHEMISTRY AND BIOTECHNOLOGY - PART 6 potx
... increased androgen and oestradiol synthes is by these cells. IGF-1 also promotes increased expression of FSH and LH receptors in ovarian tissue. 284 BIOPHARMACEUTICALS IGF biochemistry IGF-1 and -2 ... factors Bach, L. ( 199 9). The insulin-like growth factor system: basic and clinical aspects. Aust. N. Z. J. Med. 29( 3), 355–361. Cohick, W. & Clemmons, D. ( 199 3). The ins...
Ngày tải lên: 13/08/2014, 07:20
BIOPHARMACEUTICALS BIOCHEMISTRY AND BIOTECHNOLOGY - PART 4 pps
... Protein Molecular mass (kDa) IFN-a 20–27 TNF-a 52* EGF 6 IFN-b 20 GM-CSF 22 NGF 26 IFN-g 20–25 G-CSF 21 Insulin 5.7 IL-2 15–20 EPO 36 hGH 22 IL-1 17.5 TPO 60 FSH 34 IL-12 30–35 IGF-1 7.6 LH 28.5 *Biologically ... (e.g. receptors for IL-8, IL -9 and IL-10). Many contain two polypeptide components (including IL-3, IL-4 and IL-5 receptors), while a few contain three or mo re polypeptide com...
Ngày tải lên: 13/08/2014, 07:20
BIOPHARMACEUTICALS BIOCHEMISTRY AND BIOTECHNOLOGY - PART 5 doc
... cytokines (including IL-2, -4 , -5 , -6 , -7 , -1 1, -1 5 and CSFs) also play important co- stimulatory roles in the maturation of the range of blood cells. Its growth and differentiation-inducing effects ... 1673. Renauld, J. et al. ( 199 5). Interleukin -9 and its receptor: involvement in mast cell differentiation and T cell oncogenesis. J. Leukocyte Biol. 57, 353–3...
Ngày tải lên: 13/08/2014, 07:20
BIOPHARMACEUTICALS BIOCHEMISTRY AND BIOTECHNOLOGY - PART 7 ppt
... Hempstead, UK. Norman, A. ( 199 7). Hormones. Academic Press, London. O’Malley, B. ( 199 7). Hormones and Signalling. Academic Press, London. Walsh, G. & Headon, D. ( 199 4). Protein Biotechnology. Wiley, ... Drugs Today 38(6), 4 19 427. Ciszak, E., Beals, J. M., Frank, H. et al. ( 199 5). Role of C-terminal B-chain residues in insulin assembly: the structure of hexameric LysB28 ProB 2...
Ngày tải lên: 13/08/2014, 07:20
BIOPHARMACEUTICALS BIOCHEMISTRY AND BIOTECHNOLOGY - PART 8 ppsx
... therapeutics. Blood Rev. 10(4), 201–2 09. Fitzgerald, G. ( 199 6). The human pharmacology of thrombin inhibition. Coronary Artery Dis. 7(12), 91 1 91 8. Markwardt, F. ( 199 1). Hirudin and its derivatives as anticoagulant ... 8(7), 493 –503. Sawyer, R. ( 199 1). Thrombolytics and anticoagulants from leeches. Bio/Technology 9, 513–518. Schulman, S. ( 199 6). Anticoagulation in venous th...
Ngày tải lên: 13/08/2014, 07:20
BIOPHARMACEUTICALS BIOCHEMISTRY AND BIOTECHNOLOGY - PART 10 ppsx
... 207–10 IFN-a 122, 196 , 197 –8, 210–13, 520–6 IFN-b 122, 196 , 197 , 198 , 213–14 IFN-g 196 , 197 , 198 , 214–16, 278 IFN-g 1B 216 IFN-o 2 19 IFN-t 2 19 JAK–STAT pathway 202–3 PEGylated 211 receptors 199 signal ... 278 approved biopharmaceuticals 11, 502–3 haemopoietic growth factors 257–8 IL-1 232–5 IL-1a 232–3 IL-1Ra 234 IL-1b 232–3 IL-2 224, 225–32 IL-3 235–6, 257–8 IL-4 224, 236–8 IL...
Ngày tải lên: 13/08/2014, 07:20